Sign in
NMDBF Stock Price, Chart, Stats & News
NeonMind Biosciences Inc.
Save
NeonMind Biosciences Inc. (NMDBF) does not currently pay a dividend.
8,538
Market cap
–
Current P/E
–
Forward P/E
NMDBF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
NeonMind Biosciences Inc. specializes in the research, formulation, and commercialization of medicinal and psychedelic fungi aimed at treating mental health conditions. The company is actively developing a line of psilocybin-derived products, featuring various mushroom-infused preparations, specifically tailored for weight loss and management. Originally incorporated in 2019 as Flourish Mushroom Labs Inc., it rebranded to NeonMind Biosciences Inc. in April 2020.
Similar securities
Based on sector and market capitalization
Report issue